Therapeutic Antibodies against Intracellular Tumor Antigens
Abstract Monoclonal antibodies are among the most clinically effective drugs used to treat cancer. However, their target repertoire is limited as there are relatively few tumor-specific or tumor-associated cell surface or soluble antigens. Intracellular molecules represent nearly half of the human proteome and provide an untapped reservoir of potential therapeutic targets. Antibodies have been de
Abstract Monoclonal antibodies are among the most clinically effective drugs used to treat cancer. However, their target repertoire is limited as there are relatively few tumor-specific or tumor-associated cell surface or soluble antigens. Intracellular molecules represent nearly half of the human proteome and provide an untapped reservoir of potential therapeutic targets. Antibodies have been developed to target externalized antigens, have also been engineered to enter into cells or may be expressed intracellularly with the aim of binding intracellular antigens. Furthermore, intracellular…
related reading
- Frontiers | Therapeutic Antibodies against Intracellular Tumor Antigensfrontiersin.org
- Immunotherapy for Cancer - NCIcancer.gov
- In vitro-engineered non-antibody protein therapeuticsncbi.nlm.nih.gov
- Lysosome-targeting chimaeras for degradation of extracellular proteins | Naturenature.com
- RNA Interference–Based Therapy and Its Delivery Systemsncbi.nlm.nih.gov
- Immunotherapy in pediatric malignancies: current status and future perspectives - PMCncbi.nlm.nih.gov
- Targeting telomerase for cancer therapy | Oncogenenature.com
- RNA-based therapeutics: an overview and prospectusnature.com
- Boosting therapeutic potency of antibodies by taming Fc domain functions | Experimental & Molecular Medicinenature.com
- Phage Display Derived Monoclonal Antibodies: From Bench to Bedsidencbi.nlm.nih.gov
- The current state of the art and future trends in RAS-targeted cancer therapiesnature.com
- Cancer cells educate natural killer cells to a metastasis-promoting cell state - PMCpmc.ncbi.nlm.nih.gov